CANF Can-Fite BioPharma Ltd.
Fundamentals / CIK 0001536196 / USDCan-Fite BioPharma Ltd. reported $405K in revenue and a net loss of $9.83M for the fiscal year ended December 31, 2025 (down 39.9% year over year), with a -2456.8% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CANF in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025$405K -39.9% YoY
-
Operating Income FY 2025-$9.95M -2456.8% margin
-
Net Income FY 2025-$9.83M -2426.7% net margin
-
Diluted EPS FY 2025-$5.97 Split-adjusted
-
Free Cash Flow FY 2025-$8.95M -2210.1% FCF margin
-
Cash & ST Investments Dec 31, 2025$5.53M Total debt: $71K
Annual revenue and net income
10 fiscal years (2016 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $405K | $674K | $743K | $810K | $853K | $763K | $2.03M | $3.82M | $789K | $165K |
| Research & Development | $6.69M | $5.76M | $5.98M | $7.76M | $9.85M | $11.95M | $10.98M | $6.08M | $5.11M | $6.12M |
| Selling, General & Admin | -- | -- | -- | $263K | $466K | $317K | $3.06M | $3.16M | $2.87M | $2.73M |
| Total Operating Expenses | $10.36M | $8.80M | $8.94M | $10.91M | -- | -- | -- | -- | -- | -- |
| Operating Income | -$9.95M | -$8.13M | -$8.20M | -$10.10M | -$12.84M | -$14.14M | -$12.01M | -$5.41M | -$7.18M | -$8.68M |
| EBITDA | -$9.93M | -$8.12M | -$8.18M | -$10.08M | -$12.83M | -$14.13M | -$11.99M | -$5.40M | -$7.18M | -$8.68M |
| Interest Income | -- | -- | -- | -- | -- | -- | $3.11M | $51K | $633K | $374K |
| Interest Expense | $284K | $291K | $506K | -$222K | -- | -- | $693K | $1.20M | $621K | $55K |
| Income Before Tax | -$9.83M | -$7.88M | -$7.63M | -$10.17M | -$12.62M | -$14.44M | -$12.62M | -$6.57M | -$6.40M | -$8.36M |
| Income Tax Expense | -- | -- | -- | -- | -- | -- | -- | $4.0K | $29K | $29K |
| Net Income | -$9.83M | -$7.88M | -$7.63M | -$10.17M | -$12.62M | -$14.44M | -$12.62M | -$6.57M | -$6.34M | $8.26M |
| Basic EPS | -$5.97 | -$10.86 | -$17.92 | -$0.01 | -$0.03 | -$0.04 | -$0.14 | -$0.17 | -- | -- |
| Diluted EPS | -$5.97 | -$10.86 | -$17.92 | -$0.01 | -$0.03 | -$0.04 | -$0.14 | -$0.17 | -- | -- |
| Basic Shares Outstanding | 1.6M | 725.3K | 426.1K | 815.7M | 553.1M | 358.4M | 85.9M | 38.9M | 32.5M | 27.7M |
| Diluted Shares Outstanding | 1.6M | 725.3K | 426.1K | 815.7M | 553.1M | 358.4M | 85.9M | 38.9M | 32.5M | 27.7M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $5.53M | $4.83M | $4.28M | $2.98M | $4.39M | $8.27M | $2.70M | $3.62M | $3.50M |
| Short-Term Investments | $1.0K | $5.0K | $19K | $8.0K | $237K | $75K | $64K | -- | -- |
| Cash & Short-Term Investments | $5.53M | $7.88M | $8.90M | $2.99M | $4.63M | $8.34M | $2.76M | $3.62M | $3.50M |
| Accounts Receivable, Net | -- | $0 | $0 | -- | -- | -- | -- | -- | -- |
| Total Current Assets | $9.44M | $8.98M | $9.91M | $9.16M | $20.07M | $9.40M | $7.14M | $7.90M | $6.66M |
| Property, Plant & Equipment, Net | $5.0K | $27K | $29K | $42K | $47K | $50K | $36K | $47K | $28K |
| Total Non-Current Assets | $74K | $138K | $81K | $126K | $185K | $123K | $1.03M | $49K | $950K |
| Total Assets | $9.51M | $9.12M | $9.99M | $9.28M | $20.25M | $9.52M | $8.17M | $7.95M | $7.61M |
| Accounts Payable | $1.16M | $618K | $427K | $896K | $954K | $561K | $2.16M | $1.07M | $427K |
| Deferred Revenue (Current) | $405K | $405K | $622K | $783K | $818K | $334K | $469K | $926K | $330K |
| Total Current Liabilities | $2.73M | $2.05M | $2.02M | $2.50M | $2.73M | $1.27M | $3.27M | $3.12M | $1.75M |
| Deferred Revenue (Non-Current) | $1.18M | $1.58M | $1.71M | $2.29M | $3.07M | $2.16M | $2.42M | $1.82M | $846K |
| Total Non-Current Liabilities | $1.19M | $1.63M | $1.73M | $2.31M | $3.14M | $2.18M | $2.46M | $1.82M | $846K |
| Total Liabilities | $3.92M | $3.68M | $3.75M | $4.81M | $5.87M | $3.45M | $5.73M | $4.94M | $4.63M |
| Total Debt (incl. Leases) | $71K | $104K | $40K | $62K | $124K | $67K | $75K | -- | -- |
| Common Stock | -- | -- | -- | -- | $60.65M | $33.04M | $8.22M | $2.63M | $2.12M |
| Retained Earnings | -$176.2M | -$166.4M | -$158.5M | -$150.8M | -$140.7M | -$125.5M | -$110.3M | -$100.6M | -$93.70M |
| Accumulated Other Comp. Income | $1.13M | $1.13M | $1.13M | $1.13M | $1.13M | $1.13M | $1.13M | -- | -- |
| Total Stockholders' Equity | $5.59M | $5.44M | $6.24M | $4.47M | $14.38M | $6.07M | $2.44M | $3.02M | $2.98M |
| Total Equity | $5.59M | $5.44M | $6.24M | $4.47M | $14.38M | $6.07M | $2.44M | $3.02M | $2.98M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $5.53M | $4.83M | $4.28M | $2.98M | $4.39M | $8.27M | $2.70M | $3.62M |
| Short-Term Investments | $1.0K | $5.0K | $19K | $8.0K | $237K | $75K | $64K | -- |
| Cash & Short-Term Investments | $5.53M | $7.88M | $8.90M | $2.99M | $4.63M | $8.34M | $2.76M | $3.62M |
| Accounts Receivable, Net | -- | $0 | $0 | -- | -- | -- | -- | -- |
| Total Current Assets | $9.44M | $8.98M | $9.91M | $9.16M | $20.07M | $9.40M | $7.14M | $7.90M |
| Property, Plant & Equipment, Net | $5.0K | $27K | $29K | $42K | $47K | $50K | $36K | $47K |
| Total Non-Current Assets | $74K | $138K | $81K | $126K | $185K | $123K | $1.03M | $49K |
| Total Assets | $9.51M | $9.12M | $9.99M | $9.28M | $20.25M | $9.52M | $8.17M | $7.95M |
| Accounts Payable | $1.16M | $618K | $427K | $896K | $954K | $561K | $2.16M | $1.07M |
| Deferred Revenue (Current) | $405K | $405K | $622K | $783K | $818K | $334K | $469K | $926K |
| Total Current Liabilities | $2.73M | $2.05M | $2.02M | $2.50M | $2.73M | $1.27M | $3.27M | $3.12M |
| Deferred Revenue (Non-Current) | $1.18M | $1.58M | $1.71M | $2.29M | $3.07M | $2.16M | $2.42M | $1.82M |
| Total Non-Current Liabilities | $1.19M | $1.63M | $1.73M | $2.31M | $3.14M | $2.18M | $2.46M | $1.82M |
| Total Liabilities | $3.92M | $3.68M | $3.75M | $4.81M | $5.87M | $3.45M | $5.73M | $4.94M |
| Total Debt (incl. Leases) | $71K | $104K | $40K | $62K | $124K | $67K | $75K | -- |
| Common Stock | -- | -- | -- | -- | $60.65M | $33.04M | $8.22M | $2.63M |
| Retained Earnings | -$176.2M | -$166.4M | -$158.5M | -$150.8M | -$140.7M | -$125.5M | -$110.3M | -$100.6M |
| Accumulated Other Comp. Income | $1.13M | $1.13M | $1.13M | $1.13M | $1.13M | $1.13M | $1.13M | -- |
| Total Stockholders' Equity | $5.59M | $5.44M | $6.24M | $4.47M | $14.38M | $6.07M | $2.44M | $3.02M |
| Total Equity | $5.59M | $5.44M | $6.24M | $4.47M | $14.38M | $6.07M | $2.44M | $3.02M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$9.83M | -$7.88M | -$7.63M | -$10.17M | -$12.62M | -$14.44M | -$12.62M | -$6.57M | -$6.43M | -$8.39M |
| Depreciation & Amortization | $24K | $7.0K | $15K | $14K | $14K | $12K | $14K | $14K | $3.0K | $4.0K |
| Stock-Based Compensation | $340K | $362K | $261K | $263K | $466K | $355K | $385K | $535K | $192K | $322K |
| Change in Payables | $543K | $191K | -$469K | -$58K | $393K | -$1.59M | $1.08M | $644K | $293K | $816K |
| Operating Cash Flow | -$8.95M | -$7.64M | -$8.44M | -$10.80M | -$9.86M | -$12.06M | -$11.08M | -$4.16M | -$8.97M | -$8.71M |
| Capital Expenditure | -$2.0K | -$5.0K | -$2.0K | -$9.0K | -$11K | -$26K | -$3.0K | -$33K | -$7.0K | -$10K |
| Free Cash Flow | -$8.95M | -$7.64M | -$8.44M | -$10.81M | -$9.87M | -$12.09M | -$11.09M | -$4.19M | -$8.98M | -$8.72M |
| Investing Cash Flow | -$2.0K | $1.50M | $498K | $9.50M | -$14.51M | -$26K | -$3.0K | -$33K | -$29K | -$10K |
| Common Stock Issued | $2.93M | $2.22M | -- | -- | -- | -- | $10.17M | $4.39M | $4.47M | -- |
| Dividends Paid | -- | -- | -- | -- | -$2.59M | -$715K | -- | -- | -- | -- |
| Financing Cash Flow | $9.64M | $6.71M | $9.14M | -- | $20.46M | $17.68M | $10.17M | $4.39M | $4.47M | -- |
| Net Change in Cash | $703K | $547K | $1.30M | -$1.41M | -$3.88M | $5.57M | -$918K | $110K | -$4.61M | -$8.81M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -2456.8% | -1206.2% | -1103.0% | -1246.4% | -1505.5% | -1853.1% | -590.9% | -141.7% | -910.6% | -5262.4% |
| Net Profit Margin | -2426.7% | -1169.1% | -1027.5% | -1255.9% | -1478.9% | -1892.9% | -621.3% | -172.0% | -803.4% | 5004.2% |
| Return on Equity (ROE) | -175.8% | -145.0% | -122.3% | -227.5% | -87.7% | -237.8% | -517.0% | -217.9% | -212.4% | -- |
| Return on Assets (ROA) | -103.3% | -86.4% | -76.4% | -109.6% | -62.3% | -151.7% | -154.5% | -82.6% | -83.3% | -- |
| Current Ratio | 3.46x | 4.38x | 4.90x | 3.66x | 7.35x | 7.41x | 2.18x | 2.53x | 3.80x | -- |
| Quick Ratio | 2.02x | 3.84x | 4.41x | 1.19x | 1.69x | 6.57x | 0.84x | 1.16x | 2.00x | -- |
| Debt to Equity | 0.01x | 0.02x | 0.01x | 0.01x | 0.01x | 0.01x | 0.03x | -- | -- | -- |
| Revenue Growth (YoY) | -39.9% | -9.3% | -8.3% | -5.0% | +11.8% | -62.5% | -46.8% | +384.2% | +378.2% | -- |
| Net Income Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -- | -176.8% | -- |
| 5Y Revenue / Share Growth | +11456.5% | +3828.8% | +1675.7% | -95.9% | -74.1% | -- | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | -- | -- | -- | -- | -107.6% | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.